These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34526900)

  • 21. Alveolar Epithelial A2B Adenosine Receptors in Pulmonary Protection during Acute Lung Injury.
    Hoegl S; Brodsky KS; Blackburn MR; Karmouty-Quintana H; Zwissler B; Eltzschig HK
    J Immunol; 2015 Aug; 195(4):1815-24. PubMed ID: 26188061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.
    Marudamuthu AS; Shetty SK; Bhandary YP; Karandashova S; Thompson M; Sathish V; Florova G; Hogan TB; Pabelick CM; Prakash YS; Tsukasaki Y; Fu J; Ikebe M; Idell S; Shetty S
    J Biol Chem; 2015 Apr; 290(15):9428-41. PubMed ID: 25648892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis.
    Comeglio P; Filippi S; Sarchielli E; Morelli A; Cellai I; Corcetto F; Corno C; Maneschi E; Pini A; Adorini L; Vannelli GB; Maggi M; Vignozzi L
    J Steroid Biochem Mol Biol; 2017 Apr; 168():26-37. PubMed ID: 28115235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of von Hippel-Lindau Protein in Fibroblasts Protects against Bleomycin-Induced Pulmonary Fibrosis.
    Zhou Q; Chen T; Zhang W; Bozkanat M; Li Y; Xiao L; van Breemen RB; Christman JW; Sznajder JI; Zhou G
    Am J Respir Cell Mol Biol; 2016 May; 54(5):728-39. PubMed ID: 26488390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autophagy Protects Against Developing Increased Lung Permeability and Hypoxemia by Down Regulating Inflammasome Activity and IL-1β in LPS Plus Mechanical Ventilation-Induced Acute Lung Injury.
    Nosaka N; Martinon D; Moreira D; Crother TR; Arditi M; Shimada K
    Front Immunol; 2020; 11():207. PubMed ID: 32117318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CXCL6 antibody neutralization prevents lung inflammation and fibrosis in mice in the bleomycin model.
    Besnard AG; Struyf S; Guabiraba R; Fauconnier L; Rouxel N; Proost P; Uyttenhove C; Van Snick J; Couillin I; Ryffel B
    J Leukoc Biol; 2013 Dec; 94(6):1317-23. PubMed ID: 23975892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis.
    Hirani N; MacKinnon AC; Nicol L; Ford P; Schambye H; Pedersen A; Nilsson UJ; Leffler H; Sethi T; Tantawi S; Gravelle L; Slack RJ; Mills R; Karmakar U; Humphries D; Zetterberg F; Keeling L; Paul L; Molyneaux PL; Li F; Funston W; Forrest IA; Simpson AJ; Gibbons MA; Maher TM
    Eur Respir J; 2021 May; 57(5):. PubMed ID: 33214209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effect of Galectin-9 in murine model of lung emphysema: Involvement of neutrophil migration and MMP-9 production.
    Horio Y; Ichiyasu H; Kojima K; Saita N; Migiyama Y; Iriki T; Fujii K; Niki T; Hirashima M; Kohrogi H
    PLoS One; 2017; 12(7):e0180742. PubMed ID: 28704475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of high mobility group box1 in pulmonary fibrosis.
    Hamada N; Maeyama T; Kawaguchi T; Yoshimi M; Fukumoto J; Yamada M; Yamada S; Kuwano K; Nakanishi Y
    Am J Respir Cell Mol Biol; 2008 Oct; 39(4):440-7. PubMed ID: 18441281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nintedanib reduces ventilation-augmented bleomycin-induced epithelial-mesenchymal transition and lung fibrosis through suppression of the Src pathway.
    Li LF; Kao KC; Liu YY; Lin CW; Chen NH; Lee CS; Wang CW; Yang CT
    J Cell Mol Med; 2017 Nov; 21(11):2937-2949. PubMed ID: 28598023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Omentin-1 protects against bleomycin-induced acute lung injury.
    Zhou Y; Hao C; Li C; Huang X; Li X; Tang Y; Huang Y; Tang S; Liu W; Feng D; Xu J; Yue S; Xie H; Luo Z
    Mol Immunol; 2018 Nov; 103():96-105. PubMed ID: 30245266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prominin-1/CD133+ lung epithelial progenitors protect from bleomycin-induced pulmonary fibrosis.
    Germano D; Blyszczuk P; Valaperti A; Kania G; Dirnhofer S; Landmesser U; Lüscher TF; Hunziker L; Zulewski H; Eriksson U
    Am J Respir Crit Care Med; 2009 May; 179(10):939-49. PubMed ID: 19234103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated level of Galectin-1 in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis.
    Bennett D; Bargagli E; Bianchi N; Landi C; Fossi A; Fui A; Sestini P; Refini RM; Rottoli P
    Respir Physiol Neurobiol; 2020 Feb; 273():103323. PubMed ID: 31678459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-17A contributes to HSV1 infection-induced acute lung injury in a mouse model of pulmonary fibrosis.
    Chen T; Qiu H; Zhao MM; Chen SS; Wu Q; Zhou NY; Lu LQ; Song JC; Tang DL; Weng D; Li HP
    J Cell Mol Med; 2019 Feb; 23(2):908-919. PubMed ID: 30378252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolonged monocyte accumulation in the lung during bleomycin-induced pulmonary fibrosis. A noninvasive assessment of monocyte kinetics by scintigraphy.
    Doherty DE; Hirose N; Zagarella L; Cherniack RM
    Lab Invest; 1992 Feb; 66(2):231-42. PubMed ID: 1370968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-27a alleviates LPS-induced acute lung injury in mice via inhibiting inflammation and apoptosis through modulating TLR4/MyD88/NF-κB pathway.
    Ju M; Liu B; He H; Gu Z; Liu Y; Su Y; Zhu D; Cang J; Luo Z
    Cell Cycle; 2018; 17(16):2001-2018. PubMed ID: 30231673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytokine Signaling Protein 3 Deficiency in Myeloid Cells Promotes Retinal Degeneration and Angiogenesis through Arginase-1 Up-Regulation in Experimental Autoimmune Uveoretinitis.
    Chen M; Zhao J; Ali IHA; Marry S; Augustine J; Bhuckory M; Lynch A; Kissenpfennig A; Xu H
    Am J Pathol; 2018 Apr; 188(4):1007-1020. PubMed ID: 29452101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis.
    Kim TH; Lee YH; Kim KH; Lee SH; Cha JY; Shin EK; Jung S; Jang AS; Park SW; Uh ST; Kim YH; Park JS; Sin HG; Youm W; Koh ES; Cho SY; Paik YK; Rhim TY; Park CS
    Am J Respir Crit Care Med; 2010 Sep; 182(5):633-42. PubMed ID: 20463180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The intensity of chronic lung inflammation and fibrosis after bleomycin is directly related to the severity of acute injury.
    Shen AS; Haslett C; Feldsien DC; Henson PM; Cherniack RM
    Am Rev Respir Dis; 1988 Mar; 137(3):564-71. PubMed ID: 2449833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the chemokine receptor CXCR2 in bleomycin-induced pulmonary inflammation and fibrosis.
    Russo RC; Guabiraba R; Garcia CC; Barcelos LS; Roffê E; Souza AL; Amaral FA; Cisalpino D; Cassali GD; Doni A; Bertini R; Teixeira MM
    Am J Respir Cell Mol Biol; 2009 Apr; 40(4):410-21. PubMed ID: 18836137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.